Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcos de Lima

Showing results (191-200 of 321) with videos related to

Pageof 33
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 18, 2012
Significance of persistent cytogenetic abnormalities on myeloablative allogeneic stem cell transplantation in first complete remissionBetul Oran, Uday Popat, Gabriella Rondon, et al.
Revista Brasileira De Hematologia E Hemoterapia|November 20, 2016
Outcomes of allogeneic hematopoietic stem cell transplantation for lymphomas: a single-institution experienceMira Romany Massoud, Paolo Fabrizio Caimi, Nicole Ferrari, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 3, 2004
Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantationDaniel R Couriel, Rima M Saliba, Sergio Giralt, et al.
Journal of Toxicology and Environmental Health. Part A|November 16, 2023
Cylindrospermopsin exposure promotes redox unbalance and tissue damage in the liver of <i>Poecilia reticulata</i>, a neotropical fish speciesSimone Maria Teixeira de Sabóia-Morais, João Marcos de Lima Faria, Jéssica Custódio da Silva Rabelo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 20, 2010
Unrelated donor transplantation for acute myelogenous leukemia in first remissionQaiser Bashir, Borje S Andersson, Marcelo Fernandez-Vina, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 20, 2011
Treatment of FLT3-ITD-positive acute myeloid leukemia relapsing after allogeneic stem cell transplantation with sorafenibManish Sharma, Farhad Ravandi, Ulas Darda Bayraktar, et al.
Blood Advances|October 22, 2024
Siltuximab for chimeric antigen receptor T-cell therapy-related CRS and ICANS: a multicenter retrospective analysisAmneet Bajwa, Qiuhong Zhao, Marcus Geer, et al.
Blood|August 15, 2002
Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemiaHagop M Kantarjian, Susan O'Brien, Jorge E Cortes, et al.
Blood|October 5, 2011
Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantationStefan O Ciurea, Peter F Thall, Xuemei Wang, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 27, 2017
Management of Advanced and Relapsed/Refractory Extranodal Natural Killer T-Cell Lymphoma: An Analysis of Stem Cell Transplantation and Chemotherapy OutcomesJonathan E Brammer, Dai Chihara, L Michelle Poon, et al.
Pageof 33

Showing results (191-200 of 321) with videos related to

Sort By:
Pageof 33
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 18, 2012
Significance of persistent cytogenetic abnormalities on myeloablative allogeneic stem cell transplantation in first complete remissionBetul Oran, Uday Popat, Gabriella Rondon, et al.
Revista Brasileira De Hematologia E Hemoterapia|November 20, 2016
Outcomes of allogeneic hematopoietic stem cell transplantation for lymphomas: a single-institution experienceMira Romany Massoud, Paolo Fabrizio Caimi, Nicole Ferrari, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 3, 2004
Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantationDaniel R Couriel, Rima M Saliba, Sergio Giralt, et al.
Journal of Toxicology and Environmental Health. Part A|November 16, 2023
Cylindrospermopsin exposure promotes redox unbalance and tissue damage in the liver of <i>Poecilia reticulata</i>, a neotropical fish speciesSimone Maria Teixeira de Sabóia-Morais, João Marcos de Lima Faria, Jéssica Custódio da Silva Rabelo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 20, 2010
Unrelated donor transplantation for acute myelogenous leukemia in first remissionQaiser Bashir, Borje S Andersson, Marcelo Fernandez-Vina, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 20, 2011
Treatment of FLT3-ITD-positive acute myeloid leukemia relapsing after allogeneic stem cell transplantation with sorafenibManish Sharma, Farhad Ravandi, Ulas Darda Bayraktar, et al.
Blood Advances|October 22, 2024
Siltuximab for chimeric antigen receptor T-cell therapy-related CRS and ICANS: a multicenter retrospective analysisAmneet Bajwa, Qiuhong Zhao, Marcus Geer, et al.
Blood|August 15, 2002
Imatinib mesylate therapy for relapse after allogeneic stem cell transplantation for chronic myelogenous leukemiaHagop M Kantarjian, Susan O'Brien, Jorge E Cortes, et al.
Blood|October 5, 2011
Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantationStefan O Ciurea, Peter F Thall, Xuemei Wang, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 27, 2017
Management of Advanced and Relapsed/Refractory Extranodal Natural Killer T-Cell Lymphoma: An Analysis of Stem Cell Transplantation and Chemotherapy OutcomesJonathan E Brammer, Dai Chihara, L Michelle Poon, et al.
Pageof 33